Revvity (NYSE:RVTY – Get Free Report) issued an update on its FY24 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 4.55-4.75 for the period, compared to the consensus estimate of $4.65. The company issued revenue guidance of $2.76-2.82 billion, compared to the consensus revenue estimate of $2.81 billion.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently commented on the stock. KeyCorp boosted their target price on shares of Revvity from $110.00 to $126.00 and gave the company an overweight rating in a research note on Friday, February 2nd. TD Cowen boosted their price target on shares of Revvity from $123.00 to $130.00 and gave the company a buy rating in a research report on Tuesday. Stifel Nicolaus raised their price objective on shares of Revvity from $95.00 to $110.00 and gave the stock a hold rating in a report on Friday, February 2nd. UBS Group cut shares of Revvity from a buy rating to a neutral rating and lifted their target price for the company from $105.00 to $125.00 in a research note on Tuesday, January 16th. Finally, Robert W. Baird increased their price target on Revvity from $126.00 to $127.00 and gave the stock an outperform rating in a research report on Tuesday. Six investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of Moderate Buy and a consensus price target of $118.17.
Check Out Our Latest Stock Report on RVTY
Revvity Price Performance
Revvity (NYSE:RVTY – Get Free Report) last announced its quarterly earnings results on Monday, April 29th. The company reported $0.98 earnings per share for the quarter, topping analysts’ consensus estimates of $0.94 by $0.04. Revvity had a net margin of 5.49% and a return on equity of 7.37%. The company had revenue of $649.90 million for the quarter, compared to analysts’ expectations of $646.83 million. During the same period last year, the firm posted $1.01 earnings per share. The business’s quarterly revenue was down 3.7% compared to the same quarter last year. On average, equities analysts anticipate that Revvity will post 4.65 EPS for the current year.
Revvity Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 9th. Stockholders of record on Friday, July 19th will be given a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.27%. The ex-dividend date is Friday, July 19th. Revvity’s dividend payout ratio is 23.14%.
Insider Buying and Selling
In related news, insider Prahlad R. Singh sold 21,217 shares of the stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the completion of the transaction, the insider now directly owns 92,801 shares in the company, valued at $9,677,288.28. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.60% of the company’s stock.
About Revvity
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Featured Stories
- Five stocks we like better than Revvity
- The 3 Best Fintech Stocks to Buy Now
- Wall Street Believes in First Solar Stock’s Bull Cycle
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- AMD is Down 35%. Now is the Time to Buy the Dip
- Investing In Preferred Stock vs. Common Stock
- Amazon Stands Tall: New Highs Are in Sight
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.